Skip to main content
Log in

Postprandial lipemia as a risk factor for cardiovascular disease in patients with hypothyroidism

  • Original Articles
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Postprandial lipoprotein metabolism is suggested to play a role in the pathogenesis of atherosclerosis. In this study, we investigated postprandial lipemia and its relationship to cardiovascular risk factors in patients with overt and subclinical hypothyroidism. Twentynine female patients with TSH levels greater than 5 μIU/mL and 12 euthyroid control female subjects were included in the study. Fifteen patients had subclinical hypothyroidism and 14 had overt hypothyroidism. All subjects underwent an oral lipid tolerance test. If triglyceride levels increased by 80% or more, subjects were considered postprandial lipemia positive. Control, overt hypothyroid, and subclinical hypothyroid groups were not statistically different with respect to anthropometric measurements, fasting blood C-reactive protein, uric acid, homocysteine, glucose, insulin, lipoprotein (a), apolipoprotein B levels, and homeostasis model assessment index. Fasting triglyceride levels correlated positively with TSH levels. Postprandial lipemia frequency was higher in overt hypothyroid subjects than in the control group. The subclinical hypothyroid group did not differ from the hypothyroid group with respect to postprandial lipemia frequency. In subjects with TSH levels higher than 5 μIU/mL, PPL risk was increased sevenfold. The results of this study show that postprandial triglyceride metabolism is affected in hypothyroidism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kreisberg, R. A. and Oberman, A. (2002). J. Clin. Endocrinol. Metab. 87, 423–437.

    Article  PubMed  CAS  Google Scholar 

  2. Stone, N. J., Bilek, S., and Rosenbaum, S. (2005). Am. J. Cardiol. 96, 53E-59E.

    Article  PubMed  Google Scholar 

  3. Hokanson, J. E. and Austin, M. A. (1996). J. Cardiovasc. Risk 3, 213–219.

    Article  PubMed  CAS  Google Scholar 

  4. Manninen, V., Tenkanen, L., Koskinen, P., et al. (1992). Circulation 85, 37–45.

    PubMed  CAS  Google Scholar 

  5. Jeppesen, J., Hein, H. O., Suadicani, P., and Gynteiberg, F. (1998). Circulation 97, 1029–1036.

    PubMed  CAS  Google Scholar 

  6. Zilversmit, D. B. (1979). Circulation 60, 473–485.

    PubMed  CAS  Google Scholar 

  7. Cohn, J. S., McNamara, J. R., Krasinski, S. D., Russell, R. M., and Schaefer, E. J. (1989). Metabolsim 38, 484–490.

    CAS  Google Scholar 

  8. Nicholls, S. and Lundman, P. (2004). Semin. Vasc. Med. 4, 187–195.

    Article  PubMed  Google Scholar 

  9. Vigna, G. B., Delli Gatti, C., and Fellin, R. (2004). Nutr. Metab. Cardivasc. Dis. 14, 121–127.

    Article  CAS  Google Scholar 

  10. Cappola, A. R. and Ladenson, P. W. (2003). J. Clin. Endocrinol. Metab. 88, 2438–2444.

    Article  PubMed  CAS  Google Scholar 

  11. Duntas, L. H. (2002). Thyroid 12, 287–293.

    Article  PubMed  CAS  Google Scholar 

  12. Martinez-Triguero, M. L., Hernandez-Mijares, A., Nguyen, T. T., et al. (1998). Mayo Clin. Proc. 73, 837–841.

    Article  PubMed  CAS  Google Scholar 

  13. Danese, M. D., Ladenson, P. W., Meinert, C. L., and Powe, N. R. (2000). J. Clin. Endocrinol. Metab. 85, 2993–3001.

    Article  PubMed  CAS  Google Scholar 

  14. Caraccio, N., Ferrannini, E., and Monzani, F. (2002). J. Clin. Endocrinol. Metab. 87, 1533–1538.

    Article  PubMed  CAS  Google Scholar 

  15. Palmieri, E. A., Fazio, S., Lombardi, G., and Biondi, B. (2004). Treat. Endocrinol. 3, 233–244.

    Article  PubMed  Google Scholar 

  16. Ladenson, P. W. (1990). Am. J. Med. 88, 638–641.

    Article  PubMed  CAS  Google Scholar 

  17. Steinberg, A. D. (1968). Ann. Intern. Med. 68, 338–344.

    PubMed  CAS  Google Scholar 

  18. Nedrebo, B. G., Ericsson, U. B., Nygard, O., et al. (1998). Metabolism 47, 89–93.

    Article  PubMed  CAS  Google Scholar 

  19. Ozcan, O., Cakir, E., Yaman, H., et al. (2005). Clin. Endocrinol. 63, 203–206.

    Article  CAS  Google Scholar 

  20. Hueston, W. J., King, D. E., and Geesey, M. E. (2005). Clin. Endocrinol. 63, 582–587.

    Article  CAS  Google Scholar 

  21. Lithell, H., Boberg, J., Hellsing, K., et al. (1981). European Eur. J. Clin. Invest. 11, 3–10.

    CAS  Google Scholar 

  22. de Bruin, T. W., van Barlingen, H., van Linde-Sibenius, Trip, M., et al. (1993). J. Clin. Endocrinol. Metab. 76, 121–126.

    Article  PubMed  Google Scholar 

  23. Hokanson, J. E. and Austin, M. A. (1996). J. Cardiovasc. Risk 3, 213–219.

    Article  PubMed  CAS  Google Scholar 

  24. Netsel, P. J. (1964). J. Clin. Invest. 43, 943–949.

    Article  Google Scholar 

  25. Cohn, J. S., McNamara, J. R., and Schaefer, E. J. (1988). Clin. Chem. 34, 2456–2459.

    PubMed  CAS  Google Scholar 

  26. Cohn, J. S., Johnson, E. J., Millar, J. S., et al. (1993). J. Lipid. Res. 34, 2033–2040.

    PubMed  CAS  Google Scholar 

  27. Weintraub, M., Grosskopf, I., Trostanesky, Y., Charach, G., Rubinstein, A., and Stern, N. (1999). J. Clin. Endocrinol. Metab. 84, 2532–2536.

    Article  PubMed  CAS  Google Scholar 

  28. Karamanos, B. G., Thanopoulou, A. C., and Roussi-Penesi, D. P. (2001). Diabet. Med. 18, 32–39.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alptekin Gursoy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tanaci, N., Ertugrul, D.T., Sahin, M. et al. Postprandial lipemia as a risk factor for cardiovascular disease in patients with hypothyroidism. Endocr 29, 451–456 (2006). https://doi.org/10.1385/ENDO:29:3:451

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/ENDO:29:3:451

Key Words

Navigation